Add to ORKGLSE’s Kenneth Shadlen asks whether a recent Indian Supreme Court decision on pharmaceutical patents will make the country’s patent laws more effective, and how the decision may affect global access to affordable medicines
Pharmaceutical patenting plays a critical role in promoting innovation and ensuring the availability...
Pharmaceutical patenting plays a critical role in promoting innovation and ensuring the availability...
Through the Patents (Amendment) Act of 2005, the Indian Parliament revised the Patents Act of 1970 t...
Writing in Science, LSE’s Kenneth Shadlen, Bhaven Sampat (Columbia) and Tahir Amin (Harvard) debate ...
It has now been 20 years since the TRIPS Agreement, which established minimum standards for intellec...
This Note gives a brief overview of Indian patent law as it relates to pharmaceuticals, considers th...
Patent's reputation as a constructive mechanism in the developing world was not a common notion. The...
Patent's reputation as a constructive mechanism in the developing world was not a common notion. The...
Patent's reputation as a constructive mechanism in the developing world was not a common notion. The...
The Swiss drug company Novartis challenged India\u27s status as the Pharmacy of the Developing Worl...
The Indian Supreme Court’s (SC) decision in Novartis v Union of India (UOI), decided earlier this ye...
Abstract Background Glivec (imatinib mesylate), produ...
India’s trade-related aspects of Intellectual Property Rights (TRIPS) compliant Patent (Amendment) A...
Abstract Background Glivec (imatinib mesylate), produ...
India, like many developing countries, only recently began to grant pharmaceutical product patents. ...
Pharmaceutical patenting plays a critical role in promoting innovation and ensuring the availability...
Pharmaceutical patenting plays a critical role in promoting innovation and ensuring the availability...
Through the Patents (Amendment) Act of 2005, the Indian Parliament revised the Patents Act of 1970 t...
Writing in Science, LSE’s Kenneth Shadlen, Bhaven Sampat (Columbia) and Tahir Amin (Harvard) debate ...
It has now been 20 years since the TRIPS Agreement, which established minimum standards for intellec...
This Note gives a brief overview of Indian patent law as it relates to pharmaceuticals, considers th...
Patent's reputation as a constructive mechanism in the developing world was not a common notion. The...
Patent's reputation as a constructive mechanism in the developing world was not a common notion. The...
Patent's reputation as a constructive mechanism in the developing world was not a common notion. The...
The Swiss drug company Novartis challenged India\u27s status as the Pharmacy of the Developing Worl...
The Indian Supreme Court’s (SC) decision in Novartis v Union of India (UOI), decided earlier this ye...
Abstract Background Glivec (imatinib mesylate), produ...
India’s trade-related aspects of Intellectual Property Rights (TRIPS) compliant Patent (Amendment) A...
Abstract Background Glivec (imatinib mesylate), produ...
India, like many developing countries, only recently began to grant pharmaceutical product patents. ...
Pharmaceutical patenting plays a critical role in promoting innovation and ensuring the availability...
Pharmaceutical patenting plays a critical role in promoting innovation and ensuring the availability...
Through the Patents (Amendment) Act of 2005, the Indian Parliament revised the Patents Act of 1970 t...